Silver Book Fact

From 2010 to 2030, the total direct medical costs of cardiovascular disease (in 2008 dollars) are projected to triple–from $273 billion to $818 billion.

Heidenreich, PA, JG Trogdon, OA Khaviou, J Butler, K Dracup, MD Ezekowitz, EA Finkelstein, Y Hong, SC Johnston, A Khora, DM Lloyd-Jones, SA Nelson, G Nichol, D Orenstein, PW Wilson, and YJ Woo. Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association. Circ. 2011; 123: 933-44. http://circ.ahajournals.org/content/early/2011/01/24/CIR.0b013e31820a55f5.abstract

Reference

Title
Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association
Publication
Circ
Publication Date
2011
Authors
Heidenreich, PA, JG Trogdon, OA Khaviou, J Butler, K Dracup, MD Ezekowitz, EA Finkelstein, Y Hong, SC Johnston, A Khora, DM Lloyd-Jones, SA Nelson, G Nichol, D Orenstein, PW Wilson, and YJ Woo
Pages
933-44
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • Total cost of heart valve disease in the U.S.
     
  • Ischemic stroke hospital stays with an AFib diagnosis
    One in four hospital stays (in 2014) with ischemic stroke also included a diagnosis of atrial fibrillation. This is an increase from one in five stays in 1998.  
  • The prevalence of valve disease increases with age, from 0.7% in participants 18-44 to 13.3% in participants 75 years of age or older.  
  • Cost of AFib-related stroke in Medicare patients
    The incremental treatment costs associated with stroke in the year following diagnosis of atrial fibrillation are an estimated $7,907 per Medicare patient.  
  • Medical service utilization in AFib
    Medical service utilization in persons with and without atrial fibrillation